These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37222591)

  • 1. Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an
    Morrisette T; Stamper KC; Lev KL; Kebriaei R; Holger DJ; Abdul-Mutakabbir JC; Kunz Coyne AJ; Rybak MJ
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0131722. PubMed ID: 37222591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
    Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus.
    El Haj C; Benavent E; Sierra Y; Soldevila L; Rigo-Bonnin R; Torrejón B; Gomez-Junyent J; Rosselló I; Murillo O
    Int J Antimicrob Agents; 2022 Oct; 60(4):106664. PubMed ID: 36002115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
    Parra-Ruiz J; Vidaillac C; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm.
    Hall Snyder AD; Vidaillac C; Rose W; McRoberts JP; Rybak MJ
    Infect Dis Ther; 2014 Dec; 4(1):51-65. PubMed ID: 25519162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus in an
    Jahanbakhsh S; Singh NB; Yim J; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an
    Jahanbakhsh S; Singh NB; Yim J; Kebriaei R; Smith JR; Lev K; Tran TT; Rose WE; Arias CA; Rybak MJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094136
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
    Yan Q; Karau MJ; Raval YS; Patel R
    Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of tigecycline alone or in combination with rifampin against Staphylococcus epidermidis in biofilm.
    Szczuka E; Kaznowski A
    Folia Microbiol (Praha); 2014 Jul; 59(4):283-8. PubMed ID: 24390796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.
    Trobos M; Firdaus R; Svensson Malchau K; Tillander J; Arnellos D; Rolfson O; Thomsen P; Lasa I
    Microbiol Spectr; 2022 Aug; 10(4):e0218121. PubMed ID: 35762769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.
    Werth BJ
    J Antimicrob Chemother; 2017 May; 72(5):1410-1414. PubMed ID: 28158617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
    Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
    Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics.
    Daffinee KE; Piehl EC; Bleick C; LaPlante KL
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0010823. PubMed ID: 37154699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
    Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
    Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms.
    Sharafi T; Ghaemi EA; Rafiee M; Ardebili A
    Ann Clin Microbiol Antimicrob; 2024 Jan; 23(1):7. PubMed ID: 38245727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Schuetz AN; Mandrekar JN; Patel R
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus epidermidis biofilms control by N-acetylcysteine and rifampicin.
    Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
    Am J Ther; 2013; 20(4):322-8. PubMed ID: 21519220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.